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Preeclampsia (PE) is a pregnancy disorder characterized by high blood pressure and proteinuria that can
cause adverse health effects in both mother and fetus. There is no current cure for PE other than delivery
of the fetus/placenta. While the etiology is unknown, poor placentation due to aberrant signaling of
growth and angiogenic factors has been postulated as a causal factor of PE. In addition, environmental
contaminants, such as the metal cadmium (Cd), have been linked to placental toxicity and increased risk
of developing PE. Here, we use a translational study design to investigate genomic and epigenomic al-
terations in both placentas and placental trophoblasts, focused on the angiogenesis-associated trans-
forming growth factor-beta (TGF-b) pathway. Genes within the TGF-b pathway displayed increased
expression in both the preeclamptic placenta and Cd-treated trophoblasts. In addition, miRNAs that
target the TGF-b pathway were also signiﬁcantly altered within the preeclamptic placenta and Cd-treated
trophoblasts. Integrative analysis resulted in the identiﬁcation of a subset of Cd-responsive miRNAs,
including miR-26a and miR-155, common to preeclamptic placentas and Cd-treated trophoblasts. These
miRNAs have previously been linked to PE and are predicted to regulate members of the TGF-b pathway.
Results from this study provide future targets for PE treatment.
© 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Preeclampsia (PE) is a pregnancy-related condition character-
ized by hypertension and proteinuria during gestation, usually
accompanied by damage to other organ systems, such as the kid-
neys (Chaiworapongsa et al., 2014). PE affects between 5 and 8% of
pregnancies and accounts for approximately 76,000 and 500,000
deaths of women and fetuses worldwide, respectively (Berg et al.,
2010). While a precise etiology of PE is unknown, it is postulated
that an underlying factor may be poor placentation due total Sciences and Engineering,
rive, CB 7431, University of
r Ltd. This is an open access articleinadequate angiogenesis (Chaiworapongsa et al., 2014; Saito and
Nakashima, 2014).
An array of ligands and receptors are known to tightly control
angiogenesis. For example, growth factors, chemokines, cytokines,
and endogenous angiogenesis inhibitors has been observed in the
extracellular matrix (ECM) during vascularization (Brooks and
Rathmell, 2014). Reduced placental blood ﬂow upregulates the
expression of hypoxia inducible factor 1 alpha (HIF1A), vascular
endothelial growth factor (VEGF), VEGF receptor (VEGFR),
angiopoeitin-2 (ANGPT2), ﬁbroblast growth factor-3 (FGF-3), nitric
oxide synthase (NOS), and transforming growth factors (TGF-a, TGF-
b1, TGF-b3) (Harris, 2002). However, in PE, the expression of anti-
angiogenic factors such as fms-like tyrosin kinase-1 (FLT1) and its
soluble form (sFLT1) are increased allowing them to bind to pro-
angiogenic factors and inhibit angiogenic signaling (Nikuei et al.,under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
S.A. Brooks et al. / Food and Chemical Toxicology 98 (2016) 50e57 512015). Proper placentation and vascular bed expansion has been
found to be dependent on the expression of VEGF (Chaiworapongsa
et al., 2014). On the other hand, the TGF-beta superfamily has been
observed to oppose trophoblastic migration (Jones et al., 2006),
suggesting an intricate balance of growth factor expression that is
fundamental for placental health and embryo development (Nikuei
et al., 2015; Conti et al., 2013).
Environmental exposure to toxic metals has been linked to
placental toxicity/dysregulation causing improper vascularization
in the placenta (Esteban-Vasallo et al., 2012; Lazebnik et al., 1989;
Pollack et al., 2014). We have recently demonstrated a signiﬁcant
association between elevated levels of placental cadmium (Cd) and
increased odds of developing PE (Laine et al., 2015), supporting an
existing literature of this relationship (Pollack et al., 2014). Expo-
sure to Cd can occur through multiple sources, including contam-
inated food and water, as well as cigarette smoke (Satarug et al.,
2010). Alterations to the epigenetic landscape and genomic insta-
bility are potential detrimental human health effects of Cd expo-
sure. Disruption of genomic stability has been highlighted as a
feature of PE, which includes aberrant miRNA expression (Dai et al.,
2012; Gao et al., 2012; Gunel et al., 2011; Ishibashi et al., 2012; Lazar
et al., 2012; Li et al., 2013; Noack et al., 2011; Wang et al., 2012; Wu
et al., 2012; Yang et al., 2011; Zhu et al., 2009) and DNAmethylation
alterations of the TGF-b pathway (Martin et al., 2015). Additional
studies are needed to understand the underlying biology of Cd-
associated risk of PE.
In the present study, we used an integrated genomic analysis to
examine Cd-driven regulation of the TGF-b pathway in PE, utilizing
both clinical samples as well as in vitro experimentation in
placental trophoblast cells. Our analysis incorporated placental
expression of TGF-b pathway-associated genes and miRNA with
placental Cd levels, and Cd-responsive TGF-b pathway-associated
genes and miRNA in trophoblasts. This study aimed to examine
the direct effects that Cd has on the genome and epigenome of
placental cells in order to further elucidate the underlying biology
that supports the pathology of PE and to provide future therapeutic
targets for treatment.
2. Methods
2.1. Placental sample collection
Placentas from a total of 32 women (16 normotensive controls
and 16 preeclamptic cases) were included in this study. The women
received obstetric care at UNC hospitals and consented to collection
of samples at the time of birth as detailed in our previous study
(Martin et al., 2015). The American Congress of Obstetricians and
Gynecologists classiﬁed preeclampsia as sustained de novo hyper-
tension (>140/90 mmHg) and proteinuria (>300 mg of protein in a
24 h urine collection or urine protein/creatinine ratio of 0.3 mg/dL)
after 20 weeks of pregnancy. All preeclamptic women displayed
severe features of BP’ > 160/100 with neurologic dysfunction, renal
dysfunction, and/or evidence of HELLP syndrome. Women with
confounding conditions such as pre-diabetes, diabetes, and gesta-
tional diabetes were excluded from the study. A full-thickness
placental biopsy was obtained after delivery, avoiding the periph-
ery and areas of obvious infarction, ﬂash frozen in liquid nitrogen,
and subsequently stored at 80 C until analysis. Placental Cd
concentrations were measured using ICP-MS as detailed (Laine
et al., 2015). This research was approved by the Institutional Re-
view Board at the University of North Carolina (#11e2054).
2.2. Cell culture methodology
JEG-3 cells, a human placental trophoblast cell line, were usedfor all cell culture analyses. This cell line maintains characteristics
of ﬁrst trimester trophoblast cells (Matsuo and Strauss, 1994) and
has been used to assess biological effects of exposures to environ-
mental toxicants (Bergemann et al., 2003; Canettieri et al., 2008;
Ding et al., 2011; Koc et al., 2003; Matscheski et al., 2006;
Adebambo et al., 2015; Guan et al., 2013; Kummu et al., 2012;
Alvarez and Chakraborty, 2011). Cells were grown in Dulbecco’s
Eagle Minimum Essential Media with 10% FBS, sodium pyruvate,
and penicillin/streptomycin at 37 C with 5% CO2. Cd chloride
(CdCl2) was dissolved into the media by vortex for ﬁnal concen-
trations of 1, 10, and 25 mM.
2.3. Cell viability assay
Cells were seeded in 96-well black clear bottom plates at
10,000/mL with a total of 200 mL of media. Dilutions of Cd chloride
were carried out starting at 2000 mM until a ﬁnal concentration of
0.001 mM was reached. Experiments were carried out in biological
triplicate. Following a 24 or 48 h incubation, media was removed
and cell viability measured by the CellTiter-Glo Luminescent Cell
Viability Assay (Promega, Madison, WI). Luminescence was
measured using a Promega GloMax Microplate Luminometer. IC10
and IC50 concentrations were established and used for subsequent
experimentation.
2.4. Gene and miRNA expression
For clinical samples, a 0.2 g subsection of placental tissue was
cut from each frozen biopsy on dry ice, washed brieﬂy in sterile 1X
PBS to remove any residual blood, and homogenized in Buffer RLT
with B-mercaptoethanol (Qiagen, Valencia CA). DNA and RNA se-
quences greater than 18 nucleotides in length were collected using
the AllPrep DNA/RNA/miRNA Universal Kit (Qiagen, Valencia CA)
according to manufacturer’s instructions. RNA abundance was
analyzed using the Affymetrix GeneChip® Human Gene 2.0 ST array
as described previously (Rager et al., 2014). Data were RMA pro-
cessed using Partek Genomics Suite 6.4 (St Louis, Missouri). These
data are available at the Gene Expression Omnibus (GEO)
(GSE73377). For miRNAs, RNA was ampliﬁed, labeled, and hybrid-
ized on Agilent Human miRNA (8  60 k) Oligo Microarrays. The
green median signal was extracted and quantile normalized using
Partek Genomics Suite 6.4 (St Louis, Missouri). These data are
available at the Gene Expression Omnibus (GEO).
For the in vitro assays, both large and small RNAs were extracted
simultaneously from JEG-3 cells using Qiagen’s Allprep kit allowing
the puriﬁcation of a single fraction containing all RNA 18 nucle-
otides. The quantity of isolated RNA was measured with the
Nanodrop 1000 spectrophotometer, and its integrity veriﬁed by the
Agilent 2100 Bioanalyzer. A total of 200 ng of RNA was ampliﬁed,
labeled, and hybridized on Agilent Human miRNA v.16 (8  60 k)
Oligo Microarrays. The green median signal was extracted and
probes that expressed values less than 1 standard deviation from
the mean of the negative controls in more than 50% of the samples
were removed. Resulting data were quantile normalized using
Partek Genomics Suite 6.4 (St Louis, Missouri) and used for further
analyses.
2.5. Real-time PCR analysis
cDNAwas generated using either Qiagen’s RT2 First Strand kit or
miScript II RT Kit for mRNA and miRNA analysis, respectively.
Quantitative real-time reverse transcriptase polymerase chain re-
action (qRT-PCR) was performed and assessed using the TGF-b/
BMP Signaling Pathway RT2 Proﬁler PCR Array (Valencia, CA), which
tests 84 genes related to TGF-b signal transduction. Raw CT values
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statistical testing. Validation of miRNAs was completed using Qia-
gen’s miScript Primer Assays and SYBRGreen PCR kits. Experiments
were carried out in biological triplicate, and any outliers removed
prior to statistical analyses. The miRNA U6 was used as a house-
keeping gene.
2.6. Statistical analysis
To assess gene expression and miRNA differences between
preeclamptic versus non-preeclamptic placentas, multivariable
models were applied to the 53,637 probes on the Affymetrix Gen-
eChip® Human Gene 2.0 ST array and the 56,044 probes on the
Agilent Human miRNA v.16 (8  60 k) Oligo Microarrays. These
models controlled for gestational age, maternal age and race. Dif-
ferential RNA expression was statistically deﬁned using a false
discovery rate (FDR)-corrected q 0.15. Cd-associatedmRNAswere
analyzed separately among cases and controls using multivariable
regression models. The models controlled for maternal age, gesta-
tional age, race, and smoking status. Statistical signiﬁcance was
deﬁned as q  0.15. A database of miRNAs (n ¼ 651) was identiﬁed
in association with canonical members of the TGF-b pathway
involved in signal transduction using TargetScan7.0 (Lewis et al.,
2003) and miRBase (Landgraf et al., 2007). Pearson correlation
analysis was conducted to determine associations betweenmiRNAs
and their target mRNAs. Statistical signiﬁcance was set at p < 0.05.
T-tests were performed to assess statistical signiﬁcance of the
TGF-b Signaling Targets RT2 Proﬁler PCR Array data using Qiagen’s
Data Analysis Portal. CT values of the miRNA validation were used
to calculate 2^ (-delta CT) values for cells exposed to 1 mM or 10 mM
CdCl2 for 48 h and controls and used for analysis of covariance
(ANCOVA) to assess for differential miRNA expression. Differen-
tially expressed miRNA transcripts were considered statistically
signiﬁcant if q  0.15.
3. Results
3.1. Dysregulation of TGF-b pathway-targeting miRNAs in the
preeclamptic placenta
Gene expression was analyzed by genome-wide microarray
with a subsequent focused analysis on 84-targeted TGF-b pathway-
associated genes for 16 normotensive (control) and 16 preeclamptic
(cases) placentas, which resulted in the identiﬁcation of a total of 31
TGF-b pathway genes that were signiﬁcantly increased in the pre-
eclamptic placenta (Supplemental Table 1). We set out to assess
whether miRNAs may regulate the expression of these TGF-b-
associated genes. Of 651 compiled miRNAs that target canonical
members of the TGF-b pathway, 109 were identiﬁed as differen-
tially expressed in the preeclamptic placenta. ThesemiRNAs tended
to be upregulated in the preeclamptic placenta, where 63 miRNAs
displayed increased expression and 46 miRNAs displayed
decreased expression (Fig. 1A, Supplemental Table 2). These iden-
tiﬁed TGF-b pathway-associatedmiRNAs were a subset of a broader
genome-wide miRNA analysis where a total of 631 out of 861 (73%)
tested human miRNAs were differentially expressed in the pre-
eclamptic placenta, 17% (109 out of 631) of which target the TGF-b
pathway. Among these miRNAs are 52 that have previously been
shown to be altered in preeclampsia (Harapan and Yeni, 2015; Chen
and Wang, 2013) (Supplemental Table 2).
We next set out to examine the relationship between the TGF-b
pathway-associated miRNAs and their target genes of interest.
Among the 31 target genes were transforming growth factor beta-1
(TGFB1), transforming growth factor beta receptor 1 and 2 (TGFBR1/
2), SMAD family member 2 (SMAD2), SMAD family member 3(SMAD3), SMAD family member 4 (SMAD4), SMAD speciﬁc E3
ubiquitin protein ligase 1 (SMURF1), FBJ murine osteosarcoma viral
oncogene homolog (FOS), serpin peptidase inhibitor, clade E,
member 1 (SERPINE1), and growth arrest and DNA damage induc-
ible beta (GADD45B). When examining the relationship of TGF-b
targeting miRNAs to their target genes of interest, Pearson corre-
lation analysis identiﬁed a total of 128 signiﬁcant miRNA-mRNA
relationships; the identiﬁed associations were both negative
(n ¼ 50) and positive (n ¼ 78) (Supplemental Table 3). While the
relationship between the expression of miRNAs and their target
mRNAs is generally expected to have an inverse association, these
data highlight the complex mechanisms of miRNA regulation
(Supplemental Table 3). Of the 31 TGF-b pathway-associated genes,
most (n ¼ 23, 74%) displayed a signiﬁcant association with a TGFb-
associated miRNA suggesting a role for miRNAs as mediators of this
pathway.
3.2. Cd-associated dysregulation of TGF-b pathway-targeting
miRNAs in the preeclamptic placenta
Next, we performed multivariable regression analysis to test
whether miRNA expression in the placenta was associated with
placental Cd concentrations. Cd levels were assessed in both
normotensive subjects (controls; range: 1.01e10.42 ng/g) and
preeclamptics (cases; 0.35e8.01 ng/g) and examined for their re-
lationships to altered miRNA expression. As a result, 441 and 344
miRNAs were identiﬁed in controls and cases, respectively (Fig. 1B).
miRNAs that target the TGF-b pathway had robust expression
changes in relation to Cd levels, with a subset of miRNAs (n ¼ 29)
common to both cases and controls (Fig. 1C). Cd levels were asso-
ciated with substantial changes in the expression of miRNAs tar-
geting the TGF-b pathway in cases and controls, potentially
highlighting distinct Cd-induced miRNA regulation that drive the
development of PE.
3.3. Cd induces gene expression of the TGF-b pathway members in
trophoblast cells
To better understand the relationship between Cd exposure and
the regulation of the TGF-b pathway in the placenta, we performed
in vitro experiments utilizing JEG-3 cells, a human placental
trophoblast cell line. JEG-3 cells were exposed in culture to mini-
mally cytotoxic (<5% cell death) concentrations of 1 and 10 mM
CdCl2 for 48 h. These concentrations are similar to previous studies
that have used low Cd concentrations (1 mM) (Adebambo et al.,
2015; Guan et al., 2013; Kummu et al., 2012) to evaluate biolog-
ical disruptions in placental cells as a result of treatment, particu-
larly anti-migratory effects that can inﬂuence risk of PE (Alvarez
and Chakraborty, 2011). Gene expression was analyzed by RT-PCR
for 84-targeted TGF-b pathway-associated genes using RNA iso-
lated from untreated JEG-3 cells or JEG-3 cells treated with Cd
(Supplemental Table 4). Following a 48 h incubation, ﬁve unique
genes were signiﬁcantly expressed in JEG-3 cells treatedwith either
1 mM or 10 mM Cd concentrations compared to untreated cells
(Fig. 2A), with most (n ¼ 3) genes displaying increased expression
in response to Cd.
We next analyzed the effects of Cd treatment on the TGF-b
pathway-associated genes using the moderately cytotoxic (<50%
cell death) concentration of 25 mM CdCl2 for 24 and 48 h (Fig. 2B).
This concentration was selected as we aimed to contrast these
cellular responses in vitro to PE, a disease attributed to placental
toxicity. A total of 52 out of 84 genes tested (62%) displayed
signiﬁcantly altered expression after the 24 or 48 h Cd treatments
(Fig. 2B). Most of the signiﬁcantly changed genes displayed
increased expression in response to a 48 h treatment of Cd.
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increase in expression, while 6 out of 10 genes were increased after
the 24 h treatment.
3.4. Cd activates the TGF-b pathway targeting miRNAs in
trophoblast cells
Next, to investigate the regulation of the TGF-b pathway by
miRNAs, a genome-wide miRNA microarray analysis was
completed using cells treated with 48 h 25 mM CdCl2 since it dis-
played the most robust genomic response to Cd. The expression
levels of 99 out of 651 TGF-b pathway-targeting miRNAs displayed
signiﬁcantly differential expression. The majority of these miRNAs
displaying decreased expression (n ¼ 64) in relation to Cd (Fig. 3A,Supplemental Table 1). These data demonstrate a general inverse
relationship between Cd-induced gene expression of the TGF-b
pathway and the Cd-induced repression of miRNAs that target the
pathway. However, there were both positive (n ¼ 36) and negative
(n ¼ 65) correlations between the expression of TGFB-associated
miRNAs and their mRNA targets (Supplemental Table 5). These
changes were a subset of a broader genome-wide Cd-induced
miRNA response where 466 miRNAs were signiﬁcantly altered,
with 181 upregulated and 285 downregulated (Supplemental
Table 1). Similar to the preeclamptic placenta, approximately 20%
(99 out of 466) of the altered miRNAs in Cd-treated placental
trophoblast cells target the TGF-b pathway.
To further examine Cd-responsive miRNAs in trophoblasts
treated with the minimally cytotoxic concentrations, a total of six
Fig. 3. Expression of miRNAs that regulate the TGF-b pathway in Cd-treated trophoblast cells. A. Differential expression of TGF-b targeting miRNAs (n ¼ 99) from whole-
genome miRNA microarray analysis in JEG-3 placental trophoblast cells treated with 25 mM CdCl2 for 48 h. B. Quantitative PCR results of selected miRNAs in JEG-3 cells treated
with 1 mM or 10 mM CdCl2 for 48 h miR-155, miR-187*, and miR-3677 were signiﬁcantly decreased in the 1 mM group. The 10 mM group displayed signiﬁcant downregulation of miR-
187*. Cells treated with 1 mM or 10 mM CdCl2 were compared to untreated cells to determine fold-change. ANOVA analysis was used to determine signiﬁcance (*) that was deﬁned as
a p-value less than 0.05 and a q-value less than 0.15.
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JEG-3 cells treated with 1 mM or 10 mM concentrations of CdCl2 for
48 h (Fig. 3B). These miRNAs were selected because they were TGF-
b-associated miRNAs signiﬁcantly expressed in response to Cd in
the preeclamptic placenta (miR-31* and miR-3677-5p), TGF-b-
associated miRNAs previously established to be expressed in pre-
eclamptic placenta (miR-26a and miR-155), or miRNAs that had
signiﬁcant expression in JEG-3 cells exposed to 25 mM Cd for 48 h
(miR-3663-3p and miR-187*). Following ANOVA analysis, miR-155,
miR-187*, and miR-3677-5p were signiﬁcantly downregulated
compared to control in the 1 mM group, while miR-187* had
signiﬁcantly decreased expression in the 10 mM group compared to
control (Fig. 3B). Similar to the gene expression data, the minimally
cytotoxic Cd concentrations yielded fewer signiﬁcantly altered
miRNAs in Cd-treated trophoblasts compared to the moderately
cytotoxic Cd concentration. Interestingly, the TGFB-associated miR-
3677-5p was signiﬁcantly decreased in the 1 mM group while its
predicted gene target bone morphogenetic proteins 5 (BMP5)
(Garcia et al., 2011) was substantially increased (fold-change ¼ 3.8)
in response to Cd (Fig. 2A), suggesting a Cd-driven miRNA mech-
anism for the regulation of the TGF-b pathway.
3.5. A comparison of Cd-associated dysregulation of the TGF-b
pathway genes and targeting miRNAs in the preeclamptic placenta
and placental trophoblast cells
After completing miRNA analysis in both placentas and
placental cells, the 109 differentially expressed TGF-b pathway-
targeting miRNAs in the preeclamptic placenta and the 99 TGF-b
pathway-targeting miRNAs expressed in the 48 h 25 mM Cd-treated
trophoblasts were compared. Many (n ¼ 58) were common to both
groups (Fig. 4A). Furthermore, 15 TGF-b pathway-targeting miRNAs
were associated with Cd in placental trophoblasts cells, the
normotensive placenta, and the preeclamptic placenta (Fig. 4B).
miRNAs expressed in all three Cd-associated groups generally tar-
geted ligands that activate the TGF-b pathway such as BMP2 and
BMP5, as well as TGF-b pathway members responsible for signal
transduction such as TGFBR1, SMAD1, SMAD2, and SMAD5. Specif-
ically, miR-26a and miR-155, which target SMAD1 and SMAD2
respectively, were signiﬁcantly differentially expressed in all three
groups, with miR-155 signiﬁcantly decreased in 48 h 1 mM Cd-
treated trophoblast as well. Furthermore, these miRNAs were
observed to be associated with PE (Harapan and Yeni, 2015),providing further support for a possible mechanism underlying Cd-
associated PE.
Strong similarities of gene expression involving the TGF-b
pathway were observed between placentas and placental cells.
Notably, 26 signiﬁcantly expressed TGF-b pathway genes in Cd-
treated placental trophoblast cells were present within the 31
genes altered in the preeclamptic placenta. Among these were TGF-
b pathway members TGFBR1, TGFBR2, BMP2, and BMP5, which play
key roles in the signal transduction of the TGF-b and BMP signaling
pathways, and thus SMAD activation. Moreover, the downstream
targets of these pathways, SMURF1, FOS, SERPINE1, and GADD45B,
displayed increased expression in the placenta and Cd-treated
trophoblasts (Fig. 5).
4. Discussion
In the present study, we set out to elucidate a potential molec-
ular mechanism by which Cd exposure increases the risk for PE.
Using a translational approach, we integrated cell culture experi-
mentation with clinical sample analysis to establish a novel link
between the induction of genes within the TGF-b pathway both in
the preeclamptic placenta and in Cd-exposed placental cells.
Furthermore, we highlight miRNA suppression that may underlie
the induction of the TGF-b pathway in response to Cd as an
epigenetic mechanism that mediates expression. Investigating the
underlying biology of PE and potential environmental inﬂuences
can provide insight into the speciﬁc effects of toxicants on placental
molecular phenotypes that increase risk of PE, as well as better
treatment options for patients.
One of the main hypotheses for the development of PE is poor
angiogenesis in the placenta leading to a hypoxic environment.
Numerous growth factors exhibit aberrant maternal and placental
expression in preeclamptic patients as compared to women who
are normotensive during pregnancy (Nikuei et al., 2015). One family
of growth factors is TGF-b, which promotes an anti-migratory
signal in trophoblast cells. Here, we analyzed placentas from pre-
eclamptic and normotensive women, as well as JEG-3 placental
trophoblast cells treated with Cd, in order to investigate the in-
duction of the TGF-b pathway. TGF-b receptors I and II were among
the TGF-b pathway-associated genes that displayed increased
expression in relation to PE as well as placental cells exposed to Cd.
TGF-b receptors I and II activate the signal transduction of the TGF-
b pathway upon the binding of the TGF-b superfamily of ligands.
Fig. 4. Venn diagram of TGF-b pathway-targeting miRNAs in control or case placentas and trophoblast cells. TGF-b-targeting miRNAs uniquely expressed or overlapping among
25 mM Cd-treated placental trophoblast cells and the preeclamptic placenta (A). TGF-b-targeting miRNAs uniquely expressed or overlapping among Cd-treated (25 mM) placental
trophoblast cells, and placentas (cases and controls) in association with Cd.
Fig. 5. Dysregulation of the TGF-b pathway in the preeclamptic placenta and Cd-treated placental trophoblast cells. Increased (þ) or decreased () gene expression of ca-
nonical members of the TGF-b pathway in the preeclamptic placenta and JEG-3 placental trophoblast cells treated with either minimally or moderately cytotoxic CdCl2
concentrations.
S.A. Brooks et al. / Food and Chemical Toxicology 98 (2016) 50e57 55Further studies are needed to demonstrate the speciﬁc mechanism
by which Cd inﬂuences the TGF-b pathway in placentas and
placental cells.
Currently, there are no treatment options for women with PE
except for premature delivery of the placenta/fetus
(Chaiworapongsa et al., 2014). Elucidating the molecular events
that lead to PE can facilitate the development of safer treatment
options. We hypothesized that not only could Cd alter expression of
the TGF-b pathway in placentas and in placental trophoblasts, but
also that the induction of the TGF-b pathwaywas regulated through
miRNA-mediated mechanisms. We observed signiﬁcant alterations
of miRNAs that target genes associated with TGF-b in both the
preeclamptic placenta and JEG-3 cells following treatment of Cd. In
support of our ﬁndings, related to miRNA dysregulation of the
preeclamptic placenta, we identiﬁed a total of 52 miRNAs that are
dyregulated in the PE placenta and overlap with other studies
(Chen and Wang, 2013). Among these are miRNAs belonging to the
primate-speciﬁc miRNA gene cluster (C19MC) imprinted in theplacenta including miR-517c, miR-518c, miR-519d, and miR-520h
(Noguer-Dance et al., 2010). Moreover, previous studies have
elucidated associations of miR-26a and miR-155 with PE, two
miRNAs in our study that had signiﬁcant Cd-altered expression in
preeclamptic placenta, normotensive placenta, and JEG-3 cells
treated with a moderately cytotoxic Cd concentration. SMAD1 and
SMAD2, transcription factors that induce downstream TGF-b
pathway genes, are predicted targets of miR-26a and miR-155
respectively and displayed altered gene expression in the pre-
eclamptic placenta and in Cd-treated trophoblasts in this study;
highlighting potential focuses for future studies to better under-
stand Cd-mediated regulation of the TGF-b pathway.
While this study provides novel information on Cd-induced
expression and epigenetic reprogramming that can further
enhance our understanding of the genomic-epigenomic in-
teractions that can drive preeclampsia, it is not without limitations.
Further studies utilizing a larger clinical cohort of normotensive
and preeclamptic women will be needed to validate these results
S.A. Brooks et al. / Food and Chemical Toxicology 98 (2016) 50e5756and identify Cd-speciﬁc mechanism for miRNA-mediated regula-
tion of angiogenic pathways, such as TGF-b. In addition, primary
placental trophoblast cells should be used in future studies to
identify Cd-speciﬁc phenotypes of genetic and epigenetic disrup-
tion. Furthermore, future studies should also include a range of
concentrations of Cd along with other metals to examine the mo-
lecular regulation of the TGF-b pathway. Our data suggest higher Cd
concentrations may be needed in vitro to observe comparable
biological features of the preeclamptic placenta. It is also possible
that a miRNA feedback mechanism may exist to mediate the Cd-
induced expression of the TGF-b pathway, highlighting the
complexity of metal-induced toxicity in the placenta that can in-
crease risk of PE.
Taken together our results demonstrate that miRNA dysregula-
tion is a feature of PE that is impacted by Cd exposure. In both the
preeclamptic placenta and placental trophoblasts, dysregulated
miRNA signaling was associated with altered expression signaling
of the TGF-b pathway, which may ultimately diminish trophoblast
migratory capabilities. This study provides novel evidence of a
relationship between Cd-induced expression and epigenetic
reprogramming in the placenta that can further enhance our un-
derstanding of the interactions between environmental exposures
and genetics that may drive preeclampsia.
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